Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit

Journal of Critical Care

Volumn 48, Issue , 2018, Pages 172-177

  Garnacho Montero, José ^a,b   León Moya, Cristina ^c   Gutiérrez Pizarraya, Antonio ^a   Arenzana Seisdedos, Angel ^a   Vidaur, Loreto ^d   Guerrero, José Eugenio ^e   Gordón, Mónica ^f   Martín Loeches, Ignacio ^g   Rodriguez, Alejandro ^h  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b Instituto de Biomedicina de Sevilla   (Spain)

^c San Juan de Dios Del Aljarafe   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g ST JAMES S HOSPITAL   (Ireland)

^h HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYPERTENSIVE FACTOR; OSELTAMIVIR;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROPENSITY SCORE; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; CLINICAL TRIAL; HOSPITALIZATION; INFLUENZA; INFLUENZA A VIRUS (H1N1); MIDDLE AGED; MULTICENTER STUDY; ORGAN DYSFUNCTION SCORE; PROSPECTIVE STUDY; REGISTER; SPAIN; STATISTICAL MODEL;

ADULT; AGED; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SPAIN;

EID: 85053194076     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2018.08.017     Document Type: Article

References (29)

1. Estenssoro, E., Ríos, F.G., Apezteguía, C., Reina, R., Neira, J., Ceraso, D.H., et al. Registry of the Argentinian Society of Intensive Care SATI. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 182 (2010), 41–48.
2. Rodríguez, A., Díaz, E., Martín-Loeches, I., Sandiumenge, A., Canadell, L., Díaz, J.J., et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother, 66, 2011 (1140–9).
3. Maraví-Poma, E., Martin-Loeches, I., Regidor, E., Laplaza, C., Cambra, K., Aldunate, S., Severe 2009 A/H1N1v influenza in pregnant women in Spain. Crit Care Med 39 (2011), 945–951.
4. Fezeu, L., Julia, C., Henegar, A., Bitu, J., Hu, F.B., Grobbee, D.E., et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 12:8 (2011), 653–659.
5. Garnacho-Montero, J., Gutiérrez-Pizarraya, A., Márquez, J.A., Zaragoza, R., Granada, R., Ruiz-Santana, S., et al. Epidemiology, clinical features, and prognosis of elderly adults with severe forms of influenza A (H1N1). J Am Geriatr Soc 61 (2013), 350–356.
6. 1, de Cassia Nogueira Figueira G, Fred J, Albernaz RK, Carvalhanas TR, Zanetta DM. Risk factors for death from Influenza A(H1N1)pdm09, State of São Paulo, Brazil, 2009. PLoS One 2015; 10(3):e0118772.
7. López-Aldeguer, J., Iribarren, J.A., Valencia, E., Barquilla, E., Knobel, H., Santos, J., et al. Outcomes in HIV-infected patients admitted due to pandemic influenza. Enferm Infecc Microbiol Clin 30 (2012), 608–612.
8. Vilar-Compte, D., Shah, D.P., Vanichanan, J., Cornejo-Juarez, P., Garcia-Horton, A., Volkow, P., et al. Influenza in patients with hematological malignancies: experience at two comprehensive cancer centers. J Med Virol 90:1 (2018), 50–60.
9. Knaus, W.A., Wagner, D.P., Draper, E.A., Zimmerman, J.E., APACHE II: a severity of disease classification system. Crit Care Med 13 (1985), 818–829.
10. Vincent, J.L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., et al. The SOFA (Sepsis-related Organ failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22 (1996), 707–710.
11. Mehta, R.L., Kellum, J.A., Shah, S.V., Molitoris, B.A., Ronco, C., Warnock, D.G., et al. Acute kidney injury network: acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 11, 2007, R31.
12. Martin-Loeches, I., J Schultz, M., Vincent, J.L., Alvarez-Lerma, F., Bos, L.D., Solé-Violán, J., et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med 43 (2017), 48–58.
13. Álvarez-Lerma, F., Marín-Corral, J., Vilà C., Masclans, J.R., Loeches, I.M., Barbadillo, S., et al. H1N1 GETGAG/SEMICYUC Study Group. Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit. J Hosp Infect 95 (2017), 200–206.
14. Lalayanni, C., Sirigou, A., Iskas, M., Smias, C., Sakellari, I., Anagnostopoulos, A., Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect, 61, 2010 (270–2).
15. Azoulay, E., Pickkers, P., Soares, M., Perner, A., Rello, J., Bauer, P.R., et al. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 43 (2017), 1808–1819.
16. Cordero, E., Aydillo, T., Fariñas, M.C., Paño-Pardo, J.R., Pachón, J., Viasus, D., et al. Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis, 31, 2012 (547–56).
17. Hermann, B., Lehners, N., Brodhun, M., Boden, K., Hochhaus, A., Kochanek, M., et al. Influenza virus infections in patients with malignancies — characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis 36 (2017), 565–573.
18. Boikos, C., Caya, C., Doll, M.K., Kraicer-Melamed, H., Dolph, M., Delisle, G., et al. Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009–15. J Antimicrob Chemother 72 (2017), 1556–1573.
19. Ebell, M.H., WHO downgrades status of oseltamivir. BMJ, 358, 2017, 3266.
20. Giannella, M., Alonso, M., Garcia de Viedma, D., Lopez Roa, P., Catalán, P., Padilla, B., et al. Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect 17 (2011), 1160–1165.
21. van der Vries, E., Stittelaar, K.J., van Amerongen, G., Veldhuis Kroeze, E.J., de Waal, L., Fraaij, P.L., et al. Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog, 9(5), 2013, e1003343.
22. Memoli, M.J., Athota, R., Reed, S., Czajkowski, L., Bristol, T., Proudfoot, K., et al. The natural history of influenza infection in the severely immunocompromised vs non-immunocompromised hosts. Clin Infect Dis 58 (2014), 214–224.
23. Lee, N., Chan, P.K., Hui, D.S., Rainer, T.H., Wong, E., Choi, K.W., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 200 (2009), 492–500.
24. Yang, J.W., Fan, L.C., Miao, X.Y., Mao, B., Li, M.H., Lu, H.W., et al. Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis. Clin Microbiol Infect, 21, 2015 (956–63).
25. Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J.S., Lim, W.S., Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. J Infect Dis, 212, 2015 (183–94).
26. Zhang, Y., Sun, W., Svendsen, E.R., Tang, S., MacIntyre, R.C., Yang, P., et al. Do corticosteroids reduce the mortality of influenza A (H1N1) infection?. Meta Anal Crit Care, 19, Feb 20, 2015, 46.
27. Rodríguez, A., Alvarez-Rocha, L., Sirvent, J.M., Zaragoza, R., Nieto, M., Arenzana, A., et al. Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit. Med Intensiva, 36, 2012 (103–37).
28. Martin-Corral, J., Climent, C., Muñoz, R., Samper, M., Dot, I., Vilà C., et al. Patients with Influenza A (H1N1)pdm09 admitted to the ICU. Impact of the Recommendations of the SEMICYUC. Med Intensiva, Mar 17, 2018, 10.1016/j.medin.2018.02.002 pii: S0210–5691(18)30048–2. [Epub ahead of print].
29. van de Veerdonk, F.L., Kolwijck, E., Lestrade, P.P., Hodiamont, C.J., Rijnders, B.J., van Paassen, J., et al. Influenza-Associated Aspergillosis in Critically Ill Patients. Am J Respir Crit Care Med, Apr 7, 2017, 10.1164/rccm.201612-2540LE [Epub ahead of print].